Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.800
-0.040 (-2.17%)
At close: Oct 22, 2024, 4:00 PM
1.805
+0.005 (0.28%)
Pre-market: Oct 23, 2024, 6:59 AM EDT

PACB Revenue

Pacific Biosciences of California had revenue of $36.01M in the quarter ending June 30, 2024, a decrease of -24.30%. This brings the company's revenue in the last twelve months to $188.87M, up 29.24% year-over-year. In the year 2023, Pacific Biosciences of California had annual revenue of $200.52M with 56.29% growth.

Revenue (ttm)
$188.87M
Revenue Growth
+29.24%
P/S Ratio
2.54
Revenue / Employee
$237,275
Employees
796
Market Cap
490.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023200.52M72.22M56.29%
Dec 31, 2022128.30M-2.21M-1.69%
Dec 31, 2021130.51M51.62M65.43%
Dec 31, 202078.89M-12.00M-13.20%
Dec 31, 201990.89M12.27M15.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna S.A. 1.10B
Emergent BioSolutions 1.10B
Varex Imaging 832.70M
Health Catalyst 299.48M
Ginkgo Bioworks Holdings 184.34M
Talkspace 172.54M
Verve Therapeutics 20.65M
PureTech Health 468.00K
Revenue Rankings